Literature DB >> 19502982

An update on alopecia areata.

Liborka Kos1, Joseph Conlon.   

Abstract

PURPOSE OF REVIEW: Alopecia areata is one of the most frequent organ-restricted autoimmune diseases, yet its pathogenesis is still unclear. In addition, although alopecia areata often results in significant psychological distress, effective treatment is lacking. RECENT
FINDINGS: New potential susceptibility loci have been implicated, but the strongest evidence points to certain class II human leukocyte antigen alleles. There is new evidence for the collapse of hair follicle immune privilege as a key step in the pathogenesis of alopecia areata. There is also new basic science evidence for stress as a contributing factor in the development of alopecia areata. Few treatments for alopecia areata have been well evaluated in randomized trials.
SUMMARY: Although multiple potential susceptibility loci have been implicated, the genetics of alopecia areata is still unclear. The role of any potential environmental contributors is also unclear. Quality evidence for efficacy of currently used treatments for alopecia areata is lacking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502982     DOI: 10.1097/MOP.0b013e32832db986

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  15 in total

Review 1.  The role of lymphocytes in the development and treatment of alopecia areata.

Authors:  Hongwei Guo; Yabin Cheng; Jerry Shapiro; Kevin McElwee
Journal:  Expert Rev Clin Immunol       Date:  2015-09-07       Impact factor: 4.473

2.  Functionally stable plasminogen activator inhibitor-1 in a family with cardiovascular disease and vitiligo.

Authors:  Mehmet Agirbasli; Mesut Eren; Songul Yasar; Kenan Delil; Fatih Goktay; Ebru Toksoy Oner; Douglas E Vaughan
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

3.  Alopecia areata developing paralell to improvement of psoriasis during ustekinumab therapy.

Authors:  Monika Słowińska; Agnieszka Kardynal; Olga Warszawik; Joanna Czuwara; Lidia Rudnicka
Journal:  J Dermatol Case Rep       Date:  2010-04-11

4.  Association between interleukin 18 polymorphisms and alopecia areata in Koreans.

Authors:  Su Kang Kim; Hae Jeong Park; Joo-Ho Chung; Jong Woo Kim; Hosik Seok; Bark-Lynn Lew; Woo-Young Sim
Journal:  J Interferon Cytokine Res       Date:  2014-01-21       Impact factor: 2.607

5.  Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Alexandra C Villasante; Lucia M Mauro; Carmen I Perez; Lawrence A Schachner; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2011-11-01       Impact factor: 3.667

6.  Relapsing polychondritis following alopecia areata.

Authors:  John C Starr; Nidhika Taneja; George W Brasher
Journal:  Case Rep Med       Date:  2010-06-23

7.  Potential involvement of the stem cell factor receptor c-kit in alopecia areata and androgenetic alopecia: histopathological, immunohistochemical, and semiquantitative investigations.

Authors:  Md Ashrafuzzaman; Tomoko Yamamoto; Noriyuki Shibata; Takeshi Thomas Hirayama; Makio Kobayashi
Journal:  Acta Histochem Cytochem       Date:  2010-02-26       Impact factor: 1.938

8.  Overview of Alopecia: A Dermatopathologist's Perspective.

Authors:  Claudia I Vidal
Journal:  Mo Med       Date:  2015 Jul-Aug

9.  Alopecia: evaluation and treatment.

Authors:  Katherine A Gordon; Antonella Tosti
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-07-19

10.  Recovery from alopecia areata in a patient with autoimmune polyglandular syndrome type 3.

Authors:  Shinya Makino; Takeshi Uchihashi; Yasuo Kataoka; Masayoshi Fujiwara
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.